SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-102816
Filing Date
2022-09-26
Accepted
2022-09-26 06:45:56
Documents
14
Period of Report
2022-09-23
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2226617d1_8k.htm   iXBRL 8-K 30227
2 EXHIBIT 3.1 tm2226617d1_ex3-1.htm EX-3.1 7642
3 EXHIBIT 99.1 tm2226617d1_ex99-1.htm EX-99.1 9341
  Complete submission text file 0001104659-22-102816.txt   229916

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kprx-20220923.xsd EX-101.SCH 3048
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kprx-20220923_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kprx-20220923_pre.xml EX-101.PRE 22605
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2226617d1_8k_htm.xml XML 3834
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 221263571
SIC: 2834 Pharmaceutical Preparations